SEC Form 4 · accession 0001179110-16-024196
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred G Weiss
Director
Period of report
May 5, 2016
Accepted (ET)
May 9, 2016 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F1,F2 | May 5, 2016 | A | 1,188 | $210.34 | A | 26,934 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These restricted stock units shall vest 100% on the earlier of (i) the day before the 2017 Annual Shareholders Meeting or (ii) May 4, 2017.
- F2Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc. Additionally, in order to correct an administrative error, amount reported also includes fifty-two (52) additional common shares inadvertently omitted in Reporting Person's previous Form 4.